Branchioma: immunohistochemical and molecular genetic study of 23 cases highlighting frequent loss of retinoblastoma 1 immunoexpression
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články
PubMed
37962685
DOI
10.1007/s00428-023-03697-1
PII: 10.1007/s00428-023-03697-1
Knihovny.cz E-zdroje
- Klíčová slova
- And neck, Branchioma, CD34, Ectopic hamartomatous thymoma, Head, RET, Retinoblastoma 1,
- MeSH
- branchiom * patologie MeSH
- dospělí MeSH
- hybridizace in situ fluorescenční MeSH
- lidé MeSH
- molekulární biologie MeSH
- nádory brzlíku * MeSH
- nádory glandulární a epitelové * MeSH
- nádory měkkých tkání * patologie MeSH
- nádory sítnice * MeSH
- retinoblastom * genetika patologie MeSH
- thymom * MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Branchioma is an uncommon benign neoplasm with an adult male predominance, typically occurring in the lower neck region. Different names have been used for this entity in the past (ectopic hamartomatous thymoma, branchial anlage mixed tumor, thymic anlage tumor, biphenotypic branchioma), but currently, the term branchioma has been widely accepted. Branchioma is composed of endodermal and mesodermal lineage derivatives, in particular epithelial islands, spindle cells, and mature adipose tissue without preexistent thymic tissue or evidence of thymic differentiation. Twenty-three branchiomas were evaluated morphologically. Eighteen cases with sufficient tissue were assessed by immunohistochemistry, next-generation sequencing (NGS) using the Illumina Oncology TS500 panel, and fluorescence in situ hybridization (FISH) using an RB1 dual-color probe. All cases showed a biphasic morphology of epithelial and spindle cells with intermingled fatty tissue. Carcinoma arising in branchioma was detected in three cases. The neoplastic cells showed strong AE1/3 immunolabeling (100%), while the spindle cells expressed CD34, p63, and SMA (100%); AR was detected in 40-100% of nuclei (mean, 47%) in 14 cases. Rb1 showed nuclear loss in ≥ 95% of neoplastic cells in 16 cases (89%), while two cases revealed retained expression in 10-20% of tumor cell nuclei. NGS revealed a variable spectrum of likely pathogenic variants (n = 5) or variants of unknown clinical significance (n = 6). Loss of Rb1 was detected by FISH in two cases. Recent developments support branchioma as a true neoplasm, most likely derived from the rudimental embryological structures of endoderm and mesoderm. Frequent Rb1 loss by immunohistochemistry and heterozygous deletion by FISH is a real pitfall and potential confusion with other Rb1-deficient head and neck neoplasms (i.e., spindle cell lipoma), especially in small biopsy specimens.
Bioptic Laboratory Ltd Pilsen Czech Republic
Department of Pathology and Molecular Pathology University Hospital Zurich Zurich Switzerland
Department of Pathology Rutgers University New Jersey Medical School Newark NJ USA
Faculty of Medicine University of Zurich Zurich Switzerland
Head and Neck Pathology Consultations Woodland Hills CA USA
Molecular and Genetic Laboratory Bioptic Laboratory Ltd Pilsen Czech Republic
Pathology Department Regional Hospital Kolin JSC Kolin Czech Republic
School of Medicine and Pathology Queensland University of Queensland Brisbane Australia
School of Medicine and Pathology Queensland University of Queensland UQCCR Herston Australia
Zobrazit více v PubMed
Jing H, Wang J, Wei H et al (2015) Ectopic hamartomatous thymoma: report of a case and review of literature. Int J Clin Exp Pathol 8:11776–11784 PubMed PMC
Michal M, Neubauer L (1993) Carcinoma arising in ectopic hamartomatous thymoma. A previously unpublished occurrence. Report of two cases. Zentralbl Pathol 139:381–386 PubMed
Michal M, Zamecnik M, Gogora M et al (1996) Pitfalls in the diagnosis of ectopic hamartomatous thymoma. Histopathology 29:549–555 PubMed DOI
Michal M, Neubauer L, Fakan F (1996) Carcinoma arising in ectopic hamartomatous thymoma. An ultrastructural study. Pathol Res Pract. 192:610–618 (discussion 619-621) PubMed DOI
Sato K, Thompson LDR, Miyai K et al (2018) Ectopic hamartomatous thymoma: a review of the literature with report of new cases and proposal of a new name: biphenotypic branchioma. Head Neck Pathol 12:202–209 PubMed DOI
Thompson LDR, Gagan J, Washington A et al (2020) Biphenotypic branchioma: a better name than ectopic hamartomatous thymoma for a neoplasm with HRAS mutation. Head Neck Pathol 14:884–888 PubMed DOI PMC
Taniguchi N, Satou A, Ito T et al (2023) Adenocarcinoma arising in branchioma with a KRAS and TP53 mutation. Pathol Int 73(7):317–322 PubMed DOI
Baneckova M, Michal M, Vanecek T et al (2023) Branchioma with a nested/organoid morphology: molecular profiling of a distinctive potentially misleading variant and reappraisal of potential relationship to CD34-positive/Rb1-deficient tumors of the neck. Virchows Arch 483(4):541–548 PubMed DOI PMC
Fetsch JF, Laskin WB, Michal M et al (2004) Ectopic hamartomatous thymoma: a clinicopathologic and immunohistochemical analysis of 21 cases with data supporting reclassification as a branchial anlage mixed tumor. Am J Surg Pathol 28:1360–1370 PubMed DOI
Kushida Y, Haba R, Kobayashi S et al (2006) Ectopic hamartomatous thymoma: a case report with immunohistochemical study and review of the literature. J Cutan Pathol 33:369–372 PubMed DOI
Weinreb I, O’Malley F, Ghazarian D (2007) Ectopic hamartomatous thymoma: a case demonstrating skin adnexal differentiation with positivity for epithelial membrane antigen, androgen receptors, and BRST-2 by immunohistochemistry. Hum Pathol 38:1092–1095 PubMed DOI
Michal M, Rubin BP, Kazakov DV et al (2020) Inflammatory leiomyosarcoma shows frequent co-expression of smooth and skeletal muscle markers supporting a primitive myogenic phenotype: a report of 9 cases with a proposal for reclassification as low-grade inflammatory myogenic tumor. Virchows Arch 477:219–230 PubMed DOI
Skalova A, Ptakova N, Santana T et al (2019) NCOA4-RET and TRIM27-RET are characteristic gene fusions in salivary intraductal carcinoma, including invasive and metastatic tumors: is “intraductal” correct? Am J Surg Pathol 43:1303–1313 PubMed DOI
Landrum MJ, Lee JM, Benson M et al (2018) ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res 46:D1062–D1067 PubMed DOI
Michal M, Agaimy A, Contreras AL et al (2018) Dysplastic lipoma: a distinctive atypical lipomatous neoplasm with anisocytosis, focal nuclear atypia, p53 overexpression, and a lack of MDM2 gene amplification by FISH; a report of 66 cases demonstrating occasional multifocality and a rare association with retinoblastoma. Am J Surg Pathol 42:1530–1540 PubMed DOI
Michal M, Mukensnabl R (1999) Clear cell epithelial cords in an ectopic hamartomatous thymoma. Histopathology 35:89–90 PubMed DOI
Oh H, Kim E, Ahn B et al (2019) Adenocarcinoma arising in an ectopic hamartomatous thymoma with HER2 overexpression. J Pathol Transl Med 53:403–406 PubMed DOI PMC
Liang PI, Li CF, Sato Y et al (2013) Ectopic hamartomatous thymoma is distinct from lipomatous pleomorphic adenoma in lacking PLAG1 aberration. Histopathology 62:518–522 PubMed DOI
Hsieh MS, Lee YH, Jin YT et al (2020) Clinicopathological study of intraductal carcinoma of the salivary gland, with emphasis on the apocrine type. Virchows Arch 477:581–592 PubMed DOI
Bishop JA, Gagan J, Krane JF et al (2020) Low-grade apocrine intraductal carcinoma: expanding the morphologic and molecular spectrum of an enigmatic salivary gland tumor. Head Neck Pathol 14:869–875 PubMed DOI PMC
Michalova K, Kutzner H, Steiner P et al (2019) Spindle cell predominant trichodiscoma or spindle cell lipoma with adnexal induction? A study of 25 cases, revealing a subset of cases with RB1 heterozygous deletion in the spindle cell stroma. Am J Dermatopathol 41:637–643 PubMed DOI
Kutzner H, Kaddu S, Kanitakis J et al (2018) Spindle cell-predominant trichodiscoma. In: Elder DE, Massi D, Scolyer RA, Willemze R (eds) WHO classification of skin tumours, 4th en. IARC Press, Lyon, p 210
Dahlen A, Debiec-Rychter M, Pedeutour F et al (2003) Clustering of deletions on chromosome 13 in benign and low-malignant lipomatous tumors. Int J Cancer 103:616–623 PubMed DOI
Fletcher CD, Akerman M, Dal Cin P et al (1996) Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. Am J Pathol 148:623–630 PubMed PMC
Dal Cin P, Sciot R, Polito P et al (1997) Lesions of 13q may occur independently of deletion of 16q in spindle cell/pleomorphic lipomas. Histopathology 31:222–225 DOI
Bishop JA, Gagan J, Baumhoer D et al (2020) Sclerosing polycystic “adenosis” of salivary glands: a neoplasm characterized by PI3K pathway alterations more correctly named sclerosing polycystic adenoma. Head Neck Pathol 14:630–636 PubMed DOI
Hernandez-Prera JC, Saeed-Vafa D, Heidarian A et al (2022) Sclerosing polycystic adenoma: conclusive clinical and molecular evidence of its neoplastic nature. Head Neck Pathol 16:416–426 PubMed DOI
Skalova A, Baneckova M, Laco J et al (2022) Sclerosing polycystic adenoma of salivary glands: a novel neoplasm characterized by PI3K-AKT pathway alterations-new insights into a challenging entity. Am J Surg Pathol 46:268–280 PubMed DOI
Berdugo J, Rooper LM, Chiosea SI (2021) RB1, p16, and human papillomavirus in oropharyngeal squamous cell carcinoma. Head Neck Pathol 15:1109–1118 PubMed DOI PMC
Pelmus M, Guillou L, Hostein I et al (2002) Monophasic fibrous and poorly differentiated synovial sarcoma: immunohistochemical reassessment of 60 t(X;18)(SYT-SSX)-positive cases. Am J Surg Pathol 26:1434–1440 PubMed DOI
Baranov E, McBride MJ, Bellizzi AM et al (2020) A novel SS18-SSX fusion-specific antibody for the diagnosis of synovial sarcoma. Am J Surg Pathol 44:922–933 PubMed DOI PMC
Lee JC, Fletcher CD (2011) Malignant fat-forming solitary fibrous tumor (so-called “lipomatous hemangiopericytoma”): clinicopathologic analysis of 14 cases. Am J Surg Pathol 35:1177–1185 PubMed DOI
Barthelmess S, Geddert H, Boltze C et al (2014) Solitary fibrous tumors/hemangiopericytomas with different variants of the NAB2-STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features. Am J Pathol 184:1209–1218 PubMed DOI
Baneckova M, Michal M, Hajkova V et al (2022) Misleading morphologic and phenotypic features (transdifferentiation) in solitary fibrous tumor of the head and neck: report of 3 cases and review of the literature. Am J Surg Pathol 46:1084–1094 PubMed DOI
Stevens TM, Rooper LM, Bacchi CE et al (2022) Teratocarcinosarcoma-like and adamantinoma-like head and neck neoplasms harboring NAB2::STAT6: unusual variants of solitary fibrous tumor or novel tumor entities? Head Neck Pathol 16:746–754 PubMed DOI PMC